|
1
|
Rader DJ, Hoeg JM and Brewer HB Jr:
Quantitation of plasma apolipoproteins in the primary and secondary
prevention of coronary artery disease. Ann Intern Med.
120:1012–1025. 1994.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kopin L and Lowenstein CJ: Dyslipidemia.
Ann Intern Med. 167:ITC81–ITC96. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Berberich AJ and Hegele RA: A modern
approach to dyslipidemia. Endocr Rev. 43:611–653. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mascarenhas-Melo F, Sereno J,
Teixeira-Lemos E, Marado D, Palavra F, Pinto R, Rocha-Pereira P,
Teixeira F and Reis F: Implication of Low HDL-c levels in patients
with average LDL-c Levels: A focus on oxidized LDL, Large HDL
subpopulation, and adiponectin. Mediators Inflamm.
2013(e612038)2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Khatana C, Saini NK, Chakrabarti S, Saini
V, Sharma A, Saini RV and Saini AK: Mechanistic insights into the
oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med
Cell Longev. 2020(e5245308)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pei K, Gui T, Kan D, Feng H, Jin Y, Yang
Y, Zhang Q, Du Z, Gai Z, Wu J and Li Y: An overview of lipid
metabolism and nonalcoholic fatty liver disease. BioMed Res Int.
2020(4020249)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tarantino G, Balsano C, Santini SJ,
Brienza G, Clemente I, Cosimini B and Sinatti G: It is high time
physicians thought of natural products for alleviating NAFLD. Is
there sufficient evidence to use them? Int J Mol Sci.
22(13424)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tarantino G, Crocetto F, Di Vito C, Creta
M, Martino R, Pandolfo SD, Pesce S, Napolitano L, Capone D and
Imbimbo C: Association of NAFLD and insulin resistance with non
metastatic bladder cancer patients: A cross-sectional retrospective
study. J Clin Med. 10(346)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chou R, Dana T, Blazina I, Daeges M and
Jeanne TL: Statins for prevention of cardiovascular disease in
adults: Evidence report and systematic review for the US preventive
services task force. JAMA. 316:2008–2024. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Farnier M, Zeller M, Masson D and Cottin
Y: Triglycerides and risk of atherosclerotic cardiovascular
disease: An update. Arch Cardiovasc Dis. 114:132–139.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tenenbaum A and Fisman EZ: Fibrates are an
essential part of modern anti-dyslipidemic arsenal: Spotlight on
atherogenic dyslipidemia and residual risk reduction. Cardiovasc
Diabetol. 11(125)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nordestgaard BG: Triglyceride-Rich
lipoproteins and atherosclerotic cardiovascular disease: New
insights from epidemiology, genetics, and biology. Circ Res.
118:547–563. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sando KR and Knight M: Nonstatin therapies
for management of dyslipidemia: A review. Clin Ther. 37:2153–2179.
2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Widmer RJ, Flammer AJ, Lerman LO and
Lerman A: The mediterranean diet, its components, and
cardiovascular disease. Am J Med. 128:229–238. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Medina-Remón A, Casas R, Tressserra-Rimbau
A, Ros E, Martínez-González MA, Fitó M, Corella D, Salas-Salvadó J,
Lamuela-Raventos RM and Estruch R: PREDIMED Study Investigators.
Polyphenol intake from a Mediterranean diet decreases inflammatory
biomarkers related to atherosclerosis: A substudy of the PREDIMED
trial. Br J Clin Pharmacol. 83:114–128. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Annuzzi G, Bozzetto L, Costabile G, Giacco
R, Mangione A, Anniballi G, Vitale M, Vetrani C, Cipriano P, Della
Corte G, et al: Diets naturally rich in polyphenols improve fasting
and postprandial dyslipidemia and reduce oxidative stress: A
randomized controlled trial. Am J Clin Nutr. 99:463–471.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mazidi M, Katsiki N and Banach M: A
greater flavonoid intake is associated with lower total and
cause-specific mortality: A meta-analysis of cohort studies.
Nutrients. 12(2350)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kuchta A, Konopacka A, Waleron K, Viapiana
A, Wesołowski M, Dąbkowski K, Ćwiklińska A, Mickiewicz A,
Śledzińska A, Wieczorek E, et al: The effect of Cistus
incanus herbal tea supplementation on oxidative stress markers
and lipid profile in healthy adults. Cardiol J. 28:534–542.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Victoria-Montesinos D, Abellán Ruiz MS,
Luque Rubia AJ, Guillén Martínez D, Pérez-Piñero S, Sánchez Macarro
M, García-Muñoz AM, Cánovas García F, Castillo Sánchez J and
López-Román FJ: Effectiveness of consumption of a combination of
citrus fruit flavonoids and olive leaf polyphenols to reduce
oxidation of low-density lipoprotein in treatment-naïve
cardiovascular risk subjects: A randomized double-blind controlled
study. Antioxidants (Basel). 10(589)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Merola N, Castillo J, Benavente-García O,
Ros G and Nieto G: The effect of consumption of citrus fruit and
olive leaf extract on lipid metabolism. Nutrients.
9(1062)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Raposeiras-Roubin S, Rosselló X, Oliva B,
Fernández-Friera L, Mendiguren JM, Andrés V, Bueno H, Sanz J,
Martínez de Vega V, Abu-Assi E, et al: Triglycerides and residual
atherosclerotic risk. J Am Coll Cardiol. 77:3031–3041.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Schwartz GG, Abt M, Bao W, DeMicco D,
Kallend D, Miller M, Mundl H and Olsson AG: Fasting triglycerides
predict recurrent ischemic events in patients with acute coronary
syndrome treated with statins. J Am Coll Cardiol. 65:2267–2275.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Holmes MV, Asselbergs FW, Palmer TM,
Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C,
Swerdlow DI, et al: Mendelian randomization of blood lipids for
coronary heart disease. Eur Heart J. 36:539–550. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Marston NA, Giugliano RP, Im K, Silverman
MG, O'Donoghue ML, Wiviott SD, Ference BA and Sabatine MS:
Association between triglyceride lowering and reduction of
cardiovascular risk across multiple lipid-lowering therapeutic
classes: A Systematic Review and Meta-Regression Analysis of
Randomized Controlled Trials. Circulation. 140:1308–1317.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nordestgaard BG and Varbo A: Triglycerides
and cardiovascular disease. Lancet. 384:626–635. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Varbo A, Benn M, Tybjærg-Hansen A,
Jørgensen AB, Frikke-Schmidt R and Nordestgaard BG: Remnant
Cholesterol as a Causal Risk Factor for Ischemic Heart Disease. J
Am Coll Cardiol. 61:427–436. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nazir S, Jankowski V, Bender G, Zewinger
S, Rye KA and van der Vorst EPC: Interaction between high-density
lipoproteins and inflammation: Function matters more than
concentration! Adv Drug Deliv Rev. 159:94–119. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
O'Hagan R, Berg AR, Hong CG, Parel PM,
Mehta NN and Teague HL: Systemic consequences of abnormal
cholesterol handling: Interdependent pathways of inflammation and
dyslipidemia. Front Immunol. 13(972140)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Aggarwal G, May-Zhang LS, Yermalitsky V,
Dikalov S, Voynov MA, Amarnath V, Kon V, Linton MF, Vickers KC and
Davies SS: Myeloperoxidase-induced modification of HDL by
isolevuglandins inhibits paraoxonase-1 activity. J Biol Chem.
297(101019)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Meneses MJ, Silvestre R, Sousa-Lima I and
Macedo MP: Paraoxonase-1 as a regulator of glucose and lipid
homeostasis: Impact on the onset and progression of metabolic
disorders. Int J Mol Sci. 20(4049)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kudinov VA, Alekseeva OY, Torkhovskaya TI,
Baskaev KK, Artyushev RI, Saburina IN and Markin SS: High-Density
lipoproteins as homeostatic nanoparticles of blood plasma. Int J
Mol Sci. 21(8737)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Falchi A, Paolini J, Desjobert JM, Melis
A, Costa J and Varesi L: Phylogeography of Cistus creticus
L. on Corsica and Sardinia inferred by the TRNL-F and RPL32-TRNL
sequences of cpDNA. Mol Phylogenet Evol. 52:538–543.
2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cyboran-Mikołajczyk S, Pasławski R,
Pasławska U, Nowak K, Płóciennik M, Męczarska K, Oszmiański J,
Bonarska-Kujawa D, Kowalczyk P and Wawrzyńska M: Comparison of
osmotic resistance, shape and transmembrane potential of
erythrocytes collected from healthy and fed with high
fat-carbohydrates diet (HF-CD) pigs-protective effect of Cistus
incanus L. Extracts. Materials (Basel). 14(1050)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bernacka K, Bednarska K, Starzec A,
Mazurek S and Fecka I: Antioxidant and antiglycation effects of
Cistus x incanus water infusion, its phenolic components,
and respective metabolites. Molecules. 27(2432)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
EFSA Panel on Dietetic Products, Nutrition
and Allergies (NDA): Scientific Opinion on the substantiation of
health claims related to various food(s)/food constituent(s) and
protection of cells from premature aging, antioxidant activity,
antioxidant content and antioxidant properties, and protection of
DNA, proteins and lipids from oxidative damage pursuant to Article
13(1) of Regulation (EC) No 1924/2006. EFSA J. 8(1489)2010.
|
|
36
|
Jemai H, Bouaziz M, Fki I, El Feki A and
Sayadi S: Hypolipidimic and antioxidant activities of oleuropein
and its hydrolysis derivative-rich extracts from Chemlali olive
leaves. Chem Biol Interact. 176:88–98. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Giglio RV, Patti AM, Nikolic D, Li Volti
G, Al-Rasadi K, Katsiki N, Mikhailidis DP, Montalto G, Ivanova E,
Orekhov AN and Rizzo M: The effect of bergamot on dyslipidemia.
Phytomedicine. 23:1175–1181. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Miwa Y, Mitsuzumi H, Sunayama T, Yamada M,
Okada K, Kubota M, Chaen H, Mishima Y and Kibata M: Glucosyl
hesperidin lowers serum triglyceride level in hypertriglyceridemic
subjects through the improvement of very low-density lipoprotein
metabolic abnormality. J Nutr Sci Vitaminol (Tokyo). 51:460–470.
2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sánchez Macarro M, Martínez Rodríguez JP,
Bernal Morell E, Pérez-Piñero S, Victoria-Montesinos D,
García-Muñoz AM, Cánovas García F, Castillo Sánchez J and
López-Román FJ: Effect of a combination of citrus flavones and
flavanones and olive polyphenols for the reduction of
cardiovascular disease risk: An exploratory randomized,
double-blind, placebo-controlled study in healthy subjects.
Nutrients. 12(1475)2020.PubMed/NCBI View Article : Google Scholar
|
